Medtronic moves on with US thoracic graft trial
This article was originally published in Clinica
Executive Summary
Moving a step closer to the emerging US market for thoracic stent grafts, Medtronic has completed the patient enrolment phase of its VALOR clinical trial, a pivotal study assessing its Talent device for treating thoracic aortic aneurysms.